NasdaqGS:DXCMMedical Equipment
DexCom (DXCM) Launches New Stelo App As It Expands Into Four Countries
DexCom is rolling out a redesigned Stelo app in July that aims to provide more accessible and actionable glucose insights to users.
The company is preparing to launch Stelo in the UK, Australia, New Zealand, and South Korea, marking a push into new international markets.
These moves follow recent FDA clearance for over the counter pediatric use of Stelo in the U.S.
DexCom, trading on NasdaqGS:DXCM, is making these product and geographic moves as its stock trades around $70.14. The share...